Subject demethylation

As described earlier one of the possible products from the AFO reaction is dihydroxyflavonols. Simpson and coworkers took advantage of this outcome in their synthesis of the flavonol rhamnocitrin (23). Chalcone 24 was subjected to the typical AFO conditions to deliver dihydroxyflavonol 25. The isolated product was further subjected to hydrogen peroxide to afford flavonol 25a in 30% yield. However, treatment of 25 with bismuth acetate, generated in situ from bismuth carbonate and acetic acid, gave 25a in 77% yield for a respectable 52% overall yield over two steps. 25a was then selectively demethylated with anilinium chloride to deliver rhamnocitrin (23). 

Paulsen and his coworkers first synthesized (-f-)-203 from L-quebrachitol (286) by a 21-step reaction as follows. The di-O-isopropylidene derivative was oxidized to the ketone (287), and then epoxidized with dimethyl sulfox-onium-methylide to give 288, which was subjected to benzoylation, mesyla-tion, and demethylation, followed by benzylation, to afford 289. Introduction of unsaturation was accomplished by epoxidation of 289 with sodium methoxide to 290 and 291, and deoxygenation to 292. The azido group was introduced with azobis(dicarboxylate) to give 293, which was hydrogeno-lyzed, followed by deprotection to afford 203. 

In general, phase I reactions, such as oxidation and ra-demethylation are delayed in the neonate but are fully operational at or above adult levels by 4-6 months of age in the full-term neonate [27a-30]. Conjugation pathways, such as glucuronidation, do not approach adult values until 3 or 4 years of age. Sulfation activity does appear to reach adult levels in early infancy. For drugs that are subject to metabolism by both pathways, such as acetaminophen, the efficient activity of the sulfation pathway allows infants and children to compensate for low glucuronidation ability... 

In an alternate route designed to improve the yield of argemonine (5), 78 (X = CIO4) was subjected to Hofmann elimination. The resulting compound 80 was quatemized and allowed to react with potassium tcrt-butoxide to generate di-methylamino compound 81. An internal dimethylaminomercuration-demercura-tion procedure followed by N-demethylation then provided ( )-argemonine in 53% yield (123). 

Oxindole 89 was cleanly demethylated upon treatment with boron tribromide. The resulting oxindole 90 was subjected to the prenylation conditions, and the desired alkylated product 91 was obtained in 52% yield. The epoxidation/Lewis acid-mediated cyclization proved to be successful on this substrate. The epoxide product was directly treated with SnCl4 in THF to provided the desired 92. When oxindole 92 was treated with NaBHt (1.6 equivjand BF3 OEt2 (3.5 equiv) in THF, the desired 93 was obtained. The indole 93 was treated with TBDMSC1 and imidazole in DMF, to provide the required O-silylated indole, which was easily converted to the gramine 94 through the well known Mannich procedure. 

One recent related study has been reported, tying together isomescaline and schizophrenia. Through the use of radioactive labelling, the extent of de-methylation (the metabolic removal of the methyl groups from the methoxyls) was determined in both schizophrenic patients and normal subjects. When there was a loading of the person with methionine (an amino acid that is the principal source of the body s methyl groups), the schizophrenics appeared to show a lesser amount of demethylation. 

Next step of this synthesis consisted in the conversion of alcohol (17) to pisiferic acid (1) and this has been described in Fig. (3). The alcohol (17) in hexane was treated with Pb(OAc)4 in presence of iodine at room temperature to obtain the epoxy triene (19) (51%) whose structure was confirmed by spectroscopy. Treatment of (19) with acetyl p-toluene-sulfonic in dichloromethane yielded an olefinic acetate (20) and this was hydrogenated to obtain (21). The compound (22) could be isolated from (21) on subjection to reduction, oxidation and esterification respectively. The conversion of (22) to (23) was accomplished in three steps (reduction with sodium borohydride, immediate dehydration in dichloromethane and catalytic hydrogenation). Demethylation of (23) with anhydrous aluminium bromide and ethanethiol at room temperature produced pisiferic acid (1). Similar treatment of (23) with aluminium chloride and ethanethiol in dichloromethane yielded methylpisiferate (3). 

Fig (21) Ketone (179) on reduction and methylation produces (180). It is alkylated with isopropanol to obtain (181). Subjection of (181) to demethylation, methylation and oxidation yields ketone (182) which is converted to olefin (167) by reduction, tosylation and detosylation. 

CYP2B6 is present at low level (< 1 %) in the liver. It catalyzes bupropion hydroxylation, S-mephenytoin N-demethylation, is involved in the metabolism of cyclophosphamide, ifosfamide, mianserin and propofol. CYP2B6 6 has been associated with reduced bupropion clearance in vitro (Hesse 2004), but not in vivo whereas a moderate clearance increase was observed with CYP2B6 4 (Kirchheiner 2003). Bupropion (150 mg dose) has been proposed for phenotyping, but it is recommended to adjust dose based on subject weight (Faucette 2000). 

The spent bleach liquors are complicated mixtures of reaction products, only some of which have been identified. A simple classification according to the type of compounds present has been made in Table 8-4. As can be seen, lignin degradation products dominate in the spent liquors from chlorination and alkali extraction. Because of extensive demethylation of lignin, considerable amounts of methanol are present in the chlorination liquors. The amount of low molecular chlorinated aromatics is very low, but since the most toxic compounds are included in this fraction, clarification of its complicated composition has been the subject of intensive research. 

Four subjects had markedly reduced O-demethylation of dextromethorphan after they had taken moclobemide 300 mg bd for 9 days (60). A-demethylation was not affected. This result supports the hypothesis that moclobemide or a metabolite reduces the activity of the cytochrome enzyme CYP2D6. The clinical implications of this particular interaction remain to be clarified. 

---